Patents by Inventor Myron L. Seligman

Myron L. Seligman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6896899
    Abstract: A method of increasing glutathione levels in mammalian cells comprising administering an oral bolus of encapsulated pharmaceutically stabilized glutathione in a rapidly dissolving formulation to a mammal on an empty stomach. Pharmaceutical formulations including glutathione are also disclosed.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: May 24, 2005
    Assignee: Antioxidant Pharmaceuticals Corp.
    Inventors: Harry B. Demopolos, Myron L. Seligman
  • Patent number: 6586404
    Abstract: A method for the administration of glutathione orally comprising the administration of a bolus of glutathione which is pharmaceutically stabilized and encapsulated. The glutathione is administered on an empty stomach. The preferred stabilizer is ascorbic acid.
    Type: Grant
    Filed: July 22, 2002
    Date of Patent: July 1, 2003
    Assignee: Antioxidant Pharmaceuticals Corp.
    Inventors: Harry B. Demopolos, Myron L. Seligman
  • Publication number: 20020136763
    Abstract: A method of increasing glutathione levels in mammalian cells comprising administering an oral bolus of encapsulated pharmaceutically stabilized glutathione in a rapidly dissolving formulation to a mammal on an empty stomach. Pharmaceutical formulations including glutathione are also disclosed.
    Type: Application
    Filed: February 25, 2002
    Publication date: September 26, 2002
    Inventors: Harry B. Demopoulos, Myron L. Seligman
  • Patent number: 6423687
    Abstract: A method for the administration of glutathione orally comprising the administration of a bolus of glutathione which is pharmaceutically stabilized and encapsulated. The glutathione is administered on an empty stomach. The preferred stabilizer is ascorbic acid.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: July 23, 2002
    Assignee: Antioxidant Pharmaceuticals Corp.
    Inventors: Harry B. Demopolos, Myron L. Seligman
  • Patent number: 6350467
    Abstract: A method of increasing glutathione levels in mammalian cells comprising administering an oral bolus of encapsulated pharmaceutically stabilized glutathione in a rapidly dissolving formulation to a mammal on an empty stomach. Pharmaceutical formulations including glutathione are also disclosed.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: February 26, 2002
    Assignee: Antioxidant Pharmaceuticals Corp.
    Inventors: Harry B. Demopoulos, Myron L. Seligman
  • Patent number: 6204248
    Abstract: A method of altering an expression of a gene product in cells or an organism, comprising orally administering glutathione in an effective amount and under such conditions to alter a redox potential in the cells. The gene expression may be sensitive to redox potential through one or more of a process of induction, transcription, translation, post-translational modification, release, and/or through a receptor mediated process. The glutathione is preferably administered as an oral bolus of encapsulated pharmaceutically stabilized glutathione in a rapidly dissolving formulation to a mammal on an empty stomach.
    Type: Grant
    Filed: December 9, 1999
    Date of Patent: March 20, 2001
    Assignee: Antioxidant Pharmaceuticals Corp.
    Inventors: Harry B. Demopoulos, Myron L. Seligman
  • Patent number: 6159500
    Abstract: A method for the administration of glutathione orally comprising the administration of a bolus of glutathione which is pharmaceutically stabilized and encapsulated. The glutathione is administered on an empty stomach. The preferred stabilizer is ascorbic acid.
    Type: Grant
    Filed: December 31, 1997
    Date of Patent: December 12, 2000
    Assignee: Antioxidant Pharmaceuticals Corporation
    Inventors: Harry B. Demopoulos, Myron L. Seligman